|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The Challenge
The foremost challenge for pharmaceutical companies is to minimise the time spent on a clinical trial. In so doing, patients benefit faster and drug companies get their product to market more quickly, thereby earning profits as early as possible to recoup their development costs. The problems associated with clinical trials include:
Lack of control over packaging
Clinical trials departments have no control over the advancement of their development programmes because they face long delays whilst waiting for suitable scheduling time on a production line.
Blister quality
R&D teams carrying out clinical trials, stability or packaging tests need to produce blister packs of the same high quality as those produced on large packaging lines for which consumer consumption is high.
Production departments do not like small batches
It is not cost-effective for production departments to run small R&D batches on high-speed lines. Small batches are an inconvenience to the production department because they require the same amount of time and incur the same costs as those involved in setting up large batches. Often R&D simply have to get in line until a suitable gap in production scheduling can be found.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLineŽ ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLineŽ ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLineŽ is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
